With shares of United Parcel Service (NYSE:UPS) trading around $99, is UPS an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementUnited Parcel Service is a package delivery company. The company delivers packages each business day for 1.1 million shipping customers to 7.7 million consignees in over 220 countries and territories. Last year, United Parcel Service delivered an average of 16.3 million pieces per day worldwide or a total of 4.1 billion packages. It serves the global market for logistics services, which include transportation, distribution, forwarding, ground, ocean and air freight, brokerage, and financing. United Parcel Service operates in three segments — U.S. Domestic Package, International Package, and Supply Chain & Freight.
United Parcel Service on Friday warned it would miss its fourth quarter earnings targets, blaming an ��nprecedented��rise in online holiday shopping, a shortened holiday season and bad weather despite ��xtraordinary measures��to meet Christmas demand. This will be the second time the Atlanta-based package and delivery concern has missed its quarterly earnings targets.
Top 10 Forestry Stocks To Invest In Right Now: Bison Petroleum Corp (BISN)
Bison Petroleum Corp. (Bison), incorporated on February 9, 2010, is an independent American oil and gas company founded to provide the United States energy security by developing and producing oil and gas from the nation's energy heartlands. Bison's holdings are located in the Bighorn Basin, Wyoming.
On August 9, 2013, he Company entered into a Lease Purchase Agreement with Nelan Advisors Corporation (Nelan), whereby Nelan sold certain oil and gas leases issued by the State of Wyoming to Bison. Bison focuses to commence oil and gas drilling operations on these leases.
Advisors' Opinion:- [By Peter Graham]
On Friday, small cap stocks Bison Petroleum Corp (OTCMKTS: BISN) and Interactive Leisure Systems Inc (OTCMKTS: IALS) sank 16.27% and 16%, respectively, and despite being the subject of recent paid promotions or investor relation campaigns. Of course, there is nothing wrong with a properly disclosed stock promotion or paid for investor relations campaigns, but investors and traders alike need to be careful about how they get into and exit such stocks before getting badly burned. With that in mind, here is a quick look at both small cap stocks to help you decide on an investment or trading strategy for this week:
Bison Petroleum Corp (OTCMKTS: BISN) Has Given Another Corporate UpdateSmall cap Bison Petroleum Corp is a publicly traded oil and gas exploration and development company based in Salt Lake City, Utah, and dedicated to the exploration and development of domestic Energy in the Bighorn Basin of Wyoming. On Friday, Bison Petroleum Corp sank 16.27% to $1.39 for a market cap of $65.35 million plus BISN is up 396.4% since last June according to Google Finance.
Top 10 Logistics Stocks To Invest In Right Now: Nuveen Virginia Premium Income Municipal Fund (NPV)
Nuveen Virginia Premium Income Municipal Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors, Inc. and Nuveen Asset Management, LLC. It invests in the fixed income markets of Virginia. The fund invests primarily in municipal securities rated Baa/BBB or better. It invests in securities that provide income exempt from federal and Virginia income tax. The fund employs fundamental analysis with bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the S&P National Municipal Bond Index and the S&P Virginia Municipal Bond Index. Nuveen Virginia Premium Income Municipal Fund was formed on January 12, 1993 and is domiciled in the United States.
Advisors' Opinion:- [By Chuck Carnevale]
Moreover, at this point I would like to add that the real meaning of forecasting future earnings is so we can determine what the size and amount of the future cash flows that a stock under consideration might be capable of generating for us. This is important, because assessing the net present value of our expected future income stream, is at the heart of determining fair value (intrinsic value). Calculating net present value (NPV) is functionally-related to today's wide utilization of discounted cash flow (DCF) analysis as a stock selection tool. I will elaborate more on this important metric in part B of this article.
Top 10 Logistics Stocks To Invest In Right Now: United Therapeutics Corporation(UTHR)
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and internationally. It offers Remodulin, Tyvaso, and Adcirca for the treatment of pulmonary arterial hypertension (PAH). The company also develops Oral Treprostinil (UT-15C), a new drug application filed with the United States Food and Drug Administration for the treatment of PAH. Its development products under Phase III clinical trials include Oral Treprostinil (UT-15C) Combination Therapy for PAH; Ch14.18 monoclonal antibody (MAb) targeting Neuroblastoma; and Remodulin for the treatment of PAH in the United States, the United Kingdom, France, Germany, Italy, and Japan. The company?s development products under Phase I clinical trials comprise Beraprost-MR for PAH in North America, Europe, Mexico, South America, Egypt, India, South Africa, and Australia; 8H9 MAb targ eting Metastatic brain cancer; and IW001 for the treatment of Idiopathic pulmonary fibrosis and primary graft dysfunction. Its pre-clinical stage products consist of Glycobiology Antiviral Agents for viral infectious diseases; PLacental eXpanded cells targeting PAH; and pulmonary tissue replacement and remodeling products for the treatment of end-stage lung disease. The company serves pharmaceutical wholesalers through specialty pharmaceutical distributors and other distributors. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland.
Advisors' Opinion:- [By Monica Gerson]
United Therapeutics (NASDAQ: UTHR) shares reached a new 52-week high of $91.13. United Therapeutics' PEG ratio is 1.64.
DENTSPLY International (NASDAQ: XRAY) shares touched a new 52-week high of $47.65. DENTSPLY's trailing-twelve-month ROE is 15.95%.
- [By Lisa Levin]
United Therapeutics (NASDAQ: UTHR) shares rose 22.55% to $107.65. The volume of United Therapeutics shares traded was 1074% higher than normal. United Therapeutics announced the FDA approval of Orenitram Extended-Release Tablets for the treatment of pulmonary arterial hypertension. JP Morgan upgraded the stock from Underweight to Neutral and raised the target price from $62 to $90.
- [By Life Sciences Report]
AF: On the large-cap side, we like United Therapeutics Corp. (UTHR) and Vertex Pharmaceuticals Inc. (VRTX). United Therapeutics, in particular, has fallen out of favor somewhat, especially relative to the level of investor interest in the name 5-6 years back. Institutional holders have shifted from a largely biotech specialist group to a mix of value and generalist stocks. The upshot is that incremental buying on the part of healthcare specialists, as they re-engage with the name, ought to have a very positive impact on United Therapeutics' share price.
- [By John Udovich]
The biotech sector may have lost some favor on Wall Street, but there is still plenty of interesting or overlooked news about the sector and/or biotech stocks like InterMune Inc (NASDAQ: ITMN), Biogen Idec Inc (NASDAQ: BIIB), Alexion Pharmaceuticals, Inc (NASDAQ: ALXN), United Therapeutics Corporation (NASDAQ: UTHR) and TNI BioTech, Inc (OTCMKTS: TNIB):
Top 10 Logistics Stocks To Invest In Right Now: Rigel Pharmaceuticals Inc.(RIGL)
Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The company?s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.
Advisors' Opinion:- [By Max Macaluso, Ph.D.]
Early Tuesday morning, Rigel Pharmaceuticals� (NASDAQ: RIGL ) and its now-ex-partner, AstraZeneca (NYSE: AZN ) , reported late-stage clinical trial results for the experimental rheumatoid arthritis drug Fostamatinib. In the following video, health-care analyst Max Macaluso discusses why Rigel dropped 18% after the news was released and the risks that lie ahead for Rigel Pharmaceuticals.
- [By Maxx Chatsko]
Rigel Pharmaceuticals (NASDAQ: RIGL ) was kicked in the stomach earlier this month, when AstraZeneca (NYSE: AZN ) returned full rights for fostamatinib. The Big Pharma member decided to write off $140 million of assets attributed to the partnership rather than take the next steps in commercializing the drug for rheumatoid arthritis. Ouch. While it's a smart idea for AstraZeneca to walk away now, Rigel is in a tough spot with its top drug candidate receiving a vote of no confidence. There is a handful of companies that stand to benefit from fostamatinib's failure. In the following video, Fool contributor Maxx Chatsko explains what it means for investors and what the future could hold for the development-stage company. �
Top 10 Logistics Stocks To Invest In Right Now: Cardinal Financial Corporation(CFNL)
Cardinal Financial Corporation operates as the holding company for Cardinal Bank that provides banking products and services to commercial and retail customers in Virginia and greater Washington, D.C. metropolitan area. It primarily engages in accepting deposits and originating loans. The company?s deposit products include commercial and retail checking accounts, money market accounts, individual retirement accounts, regular interest-bearing savings accounts, and certificates of deposits. Its lending portfolio comprises commercial and industrial loans, commercial mortgage loans, residential mortgage loans, construction loans, home equity lines of credit, and consumer loans. The company also offers courier, telephone and Internet banking, and automatic teller machine services, as well as traveler?s checks, coin counters, wire services, and safe deposit box services. In addition, Cardinal Financial Corporation, through its other subsidiaries, involves in the origination an d acquisition of residential mortgages for sale into the secondary market in the metropolitan Washington, D.C. region, as well as provides a construction-to-permanent loan program; offers retail securities brokerage and asset management services; and provides trust, estate, custody, investment management, and retirement planning services. It operates 26 banking offices. Cardinal Financial Corporation was founded in 1997 and is headquartered in McLean, Virginia.
Advisors' Opinion:- [By Marc Bastow]
Bank holding company Cardinal Financial (CFNL) raised its quarterly dividend 33% to 8 cents per share, payable on Feb. 24 to shareholders of record as of Feb. 6.
CFNL Dividend Yield: 1.88% - [By Ben Levisohn]
Cardinal Financial (CFNL) has gained 5.8% to $17.47 after it was upgraded to Outperform from Market Perform by Keefe Bruyette & Woods.
Weatherford International (WFT) has dropped 6.3% to $14.75 before the open of trading after it announced the departure of its CFO in an 8-K filing. Wells Fargo and Raymond James both cut Weatherford’s shares as a result of the change.
Top 10 Logistics Stocks To Invest In Right Now: IDEXX Laboratories Inc (IDXX)
IDEXX Laboratories, Inc., incorporated in 1983, develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company operates through three segments: diagnostic and information technology-based products and services for the veterinary market, which it refers to as the Companion Animal Group (CAG), water quality products (Water) and products for livestock and poultry health, which it refer to as Livestock and Poultry Diagnostics (LPD). It also operates two smaller segments that consist of products for milk quality and safety (Dairy) and products for the human point-of-care medical diagnostics market (OPTI Medical). In November 2011, the Company acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri. In August 2013, IDEXX Laboratories, Inc. announced that it has acquired Madasa do Brasil Ltda.
The Company sells a range of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its primary products and services are point-of-care veterinary diagnostic products, consisting of instruments and consumables and rapid assays; veterinary reference laboratory diagnostic and consulting services used by veterinarians; diagnostic and health-monitoring products for livestock and poultry; products that test water for certain microbiological contaminants; practice management systems and services and digital radiography systems used by veterinarians; products that test milk for antibiotic residues and other contaminants, and point-of-care electrolytes and blood gas analyzers used in the human point-of-care medical diagnostics market.
Companion Animal Group
The Company markets a range of in-clinic laboratory analyzers for use in providing reference laboratory quality diagnostic results in companion animal veterinary practices, which it refers ! to as the IDEXX VetLab suite of analyzers. The Company sells two chemistry analyzers, the Catalyst Dx Chemistry Analyzer and the VetTest Chemistry Analyzer, that are used by veterinarians to measure levels of certain enzymes and other substances in blood or urine for monitoring health status and assistance in diagnosing physiologic conditions. Both instruments use consumables manufactured for IDEXX by Ortho-Clinical Diagnostics, Inc. (Ortho), a subsidiary of Johnson & Johnson, based on Ortho�� dry slide technology (Catalyst Dx slides, VetTest slides or slides). In addition, the Catalyst Dx analyzer also uses dry slide electrolyte consumables manufactured by IDEXX at OPTI Medical Systems, one of its wholly owned subsidiaries. Blood tests commonly run on these analyzers include glucose, alkaline phosphatase, alanine aminotransferase (ALT), albumin, creatinine, blood urea nitrogen (BUN), and total protein. Tests are sold individually and in prepackaged panels. Both analyzers also run a urine test called urine protein:creatinine ratio, which assists in the detection of early renal disease.
The Catalyst Dx analyzer is the Company�� chemistry analyzer. The Catalyst Dx analyzer allows a veterinarian to run multiple patient samples simultaneously; to run different sample types, including whole blood, plasma, serum and urine; to perform 28 different chemistry and electrolyte tests; and to automatically calculate other parameters and ratios important to blood chemistry analysis. Its VetLyte Electrolyte Analyzer measures three electrolytes-sodium, potassium and chloride-to aid in evaluating acid-base and electrolyte balances and assessing plasma hydration. Its VetStat Electrolyte and Blood Gas Analyzer measures electrolytes, blood gases, glucose and ionized calcium, and calculates other parameters, such as base excess and anion gap. These measurements aid veterinarians in diagnosing various disease states, evaluating fluid therapy choices and measuring respiratory function. The VetStat analyzer ru! ns single! -use disposable cassettes that contain various configurations of analytes. The VetStat analyzer and its cassettes are manufactured by OPTI Medical Systems.
The Company sells three hematology analyzers that assess the cellular components of blood, including red blood cells, white blood cells and platelets (also called a complete blood count (CBC)). These analyzers include the ProCyte Dx Hematology Analyzer, which uses laser-flow cytometry, optical fluorescence and laminar-flow impedance in its analysis; the LaserCyte Hematology Analyzer, which uses laser-flow cytometry technology in its analysis, and the IDEXX VetAutoread Hematology Analyzer. It also sells the Coag Dx Analyzer, which permits the detection and diagnosis of blood clotting disorders. The ProCyte Dx analyzer provides validated results for five species (canine, feline, equine, bovine and ferret) for up to 24 different blood parameters, providing a more complete picture of each patient�� health.
The SNAPshot Dx analyzer provides quantitative measurements of total thyroxine (T4), cortisol and bile acids to assist in the evaluation of thyroid, adrenal and liver function. The SNAPshot Dx analyzer also reads, interprets and records the results of many IDEXX rapid assay SNAP tests, including its canine SNAP 4Dx test, feline SNAP FIV/FeLV Combo test, canine SNAP cPL test, feline SNAP fPL test, SNAP Feline Triple test and canine SNAP Heartworm RT test. The IDEXX VetLab UA Analyzer provides chemical urinalysis and is validated specifically for veterinary use. The IDEXX VetLab Station (IVLS) connects and integrates the diagnostic information from all the IDEXX VetLab equipment and thus provides reference laboratory information management system capability. It sells the IVLS as an integral component of the Catalyst Dx, LaserCyte and ProCyte Dx analyzers and also as a standalone hardware platform.
The IVLS includes a user interface to input patient information, connect with a practice management system and send i! nformatio! n to run the individual analyzers. IVLS also generates one integrated patient report incorporating all of the lab work generated by the IDEXX VetLab suite; stores, retrieves and analyzes historical patient diagnostics data, including SNAP test results; and sends and receives information from practice management systems, including the IDEXX Cornerstone system, as well as a variety of third-party systems. It sells a range of single-use, handheld test kits under the SNAP name. In addition to its single-use tests, it sells a range of microwell-based test kits under the PetChek name for canine heartworm, FIV and FeLV.
The Company offers commercial reference laboratory diagnostic and consulting services to veterinarians in the United States, Canada, Europe, Australia, Japan, South Africa, China and South Korea and to bioresearch customers in the United States and Europe. The Company provides specialized veterinary consultation, telemedicine and advisory services, including radiology, cardiology, internal medicine and ultrasound consulting. It develops, markets and sells practice management systems, including hardware and software, and services that run certain functions of veterinary clinics, including managing patient electronic health records, scheduling (including boarding and grooming), reminders, billing and inventory management.
The Company markets and sells two digital radiography systems for use in the small animal veterinary hospital: the IDEXX-DR 1417 and the IDEXX I-Vision CR. Its digital radiography systems use IDEXX-PACS and IDEXX EquiView PACS picture archiving and communication system (PACS) software for the viewing, manipulation, management, storage and retrieval of the digital images generated by the digital capture plate. In September 2011, the Company launched IDEXX I-Vision Mobile, an application that allows veterinarians with the IDEXX-DR 1417 and IDEXX I-Vision CR systems, as well as its digital radiography systems, to request, view and send images using an iPa! d or an A! ndroid mobile tablet. This application integrates with its IDEXX-PACS software.
Water
The Company offers a range of products used in the detection and quantification of various microbiological parameters in water. Its principal products are the Colilert, Colilert-18 and Colisure tests, which simultaneously detect the presence of total coliforms and E. coli in water. These organisms are used as indicators of microbial contamination in water. These products utilize indicator-nutrients that produce a change in color or fluorescence when metabolized by target microbes in the sample. Its water tests are used by government laboratories, water utilities and private certified laboratories to test drinking water. The tests also are used in evaluating water used in production processes (for example, in beverage and pharmaceutical applications) and in evaluating bottled water, recreational water, waste water and water from private wells.
Livestock and Poultry Diagnostics
The Company sells diagnostic tests and related instrumentation that are used to detect a range of diseases and to monitor health status in livestock and poultry. Its livestock and poultry diagnostic products are purchased by government and private laboratories that provide testing services to cattle, swine and poultry veterinarians and producers. Its principal products include tests for Bovine Viral Diarrhea Virus (BVDV), Porcine Reproductive and Respiratory Syndrome (PRRS) and Bovine Spongiform Encephalopathy (BSE or mad cow disease). BVDV is a common and contagious viral infection that suppresses the immune system, making the animal susceptible to a host of other infections, impacting beef and dairy production yields as a result. PRRS is a contagious virus causing reproductive problems and respiratory diseases. BSE is a fatal neurodegenerative disease in cattle that causes a spongy degeneration in the brain and spinal cord.
Other
The principal products in the Company�! � Dairy ! business are its SNAP tests used to detect antibiotic drug-residue in milk. Its primary product line for detecting antibiotic residue in milk is SNAP Beta-Lactam, which detects penicillin, amoxicillin, ceftiofur and cephaphirin residues, followed by SNAPduo Beta-Tetra, which detects certain tetracycline antibiotic residues in addition to those detected by the SNAP Beta Lactam test kits. It also sells SNAP tests for the detection of certain other contaminants in milk, such as chemical melamine and Alfatoxin M1.
The Company sells OPTI point-of-care analyzers and related consumables for use in human medical hospitals and clinics to measure electrolytes, blood gases, acid-base balance, glucose, lactate, BUN and ionized calcium, and to calculate other parameters, such as base excess and anion gap. These analyzers are used primarily in emergency rooms, operating rooms, cardiac monitoring areas and other locations where time-critical diagnostic testing is performed within the hospital setting. The OPTI CCA and OPTI Touch Electrolyte and Blood Gas Analyzers run single-use disposable cassettes that contain various configurations of analytes; the OPTI R Analyzer runs reusable cassettes in various analyte configurations; and the OPTI LION Stat Electrolyte Analyzer runs single-use electrolyte cassettes. OPTI Medical Systems also manufactures its VetStat analyzer and provides the electrolyte module and dry slide reagents that make up the electrolyte testing functionality of the Catalyst Dx analyzer.
The Company competes with VCA Antech, Inc., Abaxis, Inc., Butler, Radiometer A/S, Siemens Medical Solutions Diagnostics, Instrumentation Laboratory, Abbott Diagnostics and Roche Diagnostics.
Advisors' Opinion:- [By Sean Williams]
On the diagnostic side, there isn't a company better equipped to help veterinarians diagnose bone and organ disease, or help veterinarians improve the efficiency of their software, than IDEXX Laboratories (NASDAQ: IDXX ) . From small diagnostic analyzers to high-tech digital imagery and even consultation calls, IDEXX does it all for owners and veterinarians. The best part is that the company's companion diagnostics make up the bulk (83%) of its revenue, so the chance of IDEXX seeing a slowdown in demand appears pretty minimal.
- [By Sean Williams]
Ignore this trend at your own risk
If you choose to do nothing, then you're playing right into the hands of pharmaceutical giants like Zoetis (NYSE: ZTS ) , Merck (NYSE: MRK ) , and IDEXX Laboratories (NASDAQ: IDXX ) , which are counting on your indifference to drive their profits. - [By Tim Brugger]
After 10 years on the board of IDEXX Laboratories (NASDAQ: IDXX ) , including serving on its audit and compensation committees, Brian McKeon has been named IDEXX's new executive vice president and CFO, the company announced today. McKeon's appointment as CFO becomes effective Jan. 1, though he has resigned from the IDEXX board as of Oct. 11, the company said.
Top 10 Logistics Stocks To Invest In Right Now: USEC Inc (USU)
USEC Inc. (USEC) is a global energy company, is a supplier of low enriched uranium (LEU) for commercial nuclear power plants. The Company operates in two segments: the low enriched uranium (LEU) segment with two components, separative work units (SWU) and uranium, and the contract services segment. The LEU segment is its primary business focus and includes sales of the SWU component of LEU, sales of both SWU and uranium components of LEU, and sales of uranium. The contract services segment includes work performed for Department of Energy (DOE) and its contractors at Portsmouth and Paducah, as well as nuclear energy services and technologies provided by NAC International Inc. (NAC). The Company supply LEU to both domestic and international utilities for use in about 150 nuclear reactors worldwide. The Company enriches uranium at the Paducah gaseous diffusion plant (GDP) that it leases from the United States DOE.
The Company is deploying advanced uranium enrichment technology, known as the American Centrifuge. USEC provide transportation and storage systems for spent nuclear fuel and provide nuclear and energy consulting services. It also performs contract work for DOE and its contractors at the Paducah and Portsmouth sites.
Low Enriched Uranium
The majority of the Company's customers are domestic and international utilities that operate nuclear power plants. During the year ended December 31, 2011, LEU segment�� international sales constituting 23% of revenue. Its agreements with electric utilities are primarily long-term, fixed-commitment contracts under which the Company's customers are obligated to purchase a specified quantity of SWU from the Company or long-term requirements contracts under which its customers are obligated to purchase a percentage of their SWU requirements from the Company.
Contract Services
The Company performs and earns revenue from contracts work through its subsidiary NAC and from contract work for DOE and DOE! contractors at the Paducah GDP and the site of the former Portsmouth GDP in Piketon, Ohio. NAC provides nuclear energy services and technologies, specializing in design, fabrication and implementation of spent nuclear fuel technologies including the high capacity MAGNASTOR system; nuclear materials transportation, and nuclear fuel cycle consulting services.
The Company competes with Urenco, Areva, State Atomic Energy Corporation and GE Hitachi Global Laser Enrichment (GLE).
Advisors' Opinion:- [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]
Among the companies with shares expected to actively trade in Wednesday’s session are Navistar International Corp.(NAV), Smith & Wesson Holding Corp.(SWHC) and USEC Inc.(USU)
- [By John Udovich]
Small cap nuclear fuel stock USEC Inc (NYSE: USU) is up some 300% this week���meaning its worth taking a closer look at the company along with the performance potential uranium or nuclear stock peers Uranium Resources, Inc (NASDAQ: URRE), Denison Mines Corp (NYSEMKT: DNN), Ur-Energy Inc (NYSEMKT: URG) and Uranerz Energy Corp (NYSEMKT: URZ).
